Leqembi is the first drug shown to slow Alzheimer's. Why is it off to a slow start? | Tom Murphy
The first drug shown to slow Alzheimer’s disease hit the US market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage. Doctors also expect some patients will hesitate to take Leqembi due to its limited…